Healthcare systems are under pressure from a multiplicity of sometimes confounding factors, such as increasing backlogs created by the COVID-19 pandemic, staff shortages, changing population demographics, rising prevalence of chronic diseases, and the spread of infectious diseases.

For the situation to improve, there needs to be a rethinking of the approach to healthcare management and practices, including how broader use of in vitro diagnostic point-of-care (IVD POC) testing could be used to help better inform treatment decision-making in the acute setting.

To better understand the scope for increased adoption and expansion of POC testing beyond what is currently available, TTP commissioned a survey of UK and US emergency department (ED) based healthcare professionals (HCPs), specifically doctors, nurses, and paramedics.

In this report, we present the survey’s key findings and examine the opportunities and important considerations for IVD POC testing in the United Kingdom and the United States – within the ED as well as the wider community setting.

You can access the full report here.

Dr Giles Sanders
Head of In Vitro Diagnostics